The Asia-Pacific drug discovery informatics market is projected to grow at a significant CAGR of 10.8% during the forecast period. The growing demand for cloud-based solutions in the pharmaceutical sector in various countries such as China, India, and Japan further provide a significant opportunity to the drug discovery informatics market in the region. The significant adoption of the NGS technologies for clinical research further increases the need for cloud technologies. The increasing presence of major cloud service providers, including IBM Corp. and Microsoft Corp. will likely offer an opportunity to accelerate demand for cloud platforms coupled with informatics tools in the emerging pharmaceutical industry in the region.
Moreover, the integration of AI technology in the healthcare sector in the region further provides substantial opportunity to the drug discovery informatics market. For instance, in January 2018, the Government of China has planned to invest $2.12 billion in the development of an AI technology park near Beijing. The park aims to promote companies working in the field of big data, deep learning, and cloud computing. Alibaba Group is one of the major players working in the field of medical cloud computing and AI in the country. In 2016, Alibaba Cloud team up with Intel and BGI Genomics to initiate a bioinformatics analysis platform that will be able to sequence the entire human genome within a day.
To Request a Sample of our Report on Asia-Pacific Drug Discovery Informatics Market: https://www.omrglobal.com/request-sample/asia-pacific-drug-discovery-informatics-market
Asia-Pacific Drug Discovery Informatics Market – Segmentation
By Function
- Docking
- Molecular Modeling
- Libraries and Database Preparation
- Sequencing and Target Data Analysis
- Others
By End-User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organization (CRO)
- Others (Research Institutes)
A full Report of Asia-Pacific Drug Discovery Informatics Market is Available @ https://www.omrglobal.com/industry-reports/asia-pacific-drug-discovery-informatics-market
Asia-Pacific Drug Discovery Informatics Market – Segmentation by Geography
- China
- India
- Japan
- Rest of Asia-Pacific
Company Profiles
- Accenture PLC
- Charles River Laboratories, Inc.
- Cognizant Function Solutions Corp.
- Dassault Systèmes SE
- Eurofins GSC Lux SARL
- GVK Biosciences Pvt. Ltd.
- Jubilant Pharma, Ltd.
- Infosys, Ltd.
- IBM Corp.
- Novo Informatics Pvt. Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-drug-discovery-informatics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
